Hyperbaric oxygenation therapy for cyclophosphamide-induced haemorrhagic cystitis. | Canada Hyperbarics Skip to main content
Clinical Study International urology and nephrology 1995

Hyperbaric oxygenation therapy for cyclophosphamide-induced haemorrhagic cystitis.

Yazawa H, Nakada T, Sasagawa I, Miura M, Kubota Y — International urology and nephrology, 1995

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers treated a 41-year-old female patient suffering from cyclophosphamide-induced haemorrhagic cystitis with hyperbaric oxygenation therapy.

What They Found

The patient received daily hyperbaric oxygenation (100% oxygen at 2 atmospheric absolute pressures for 60 minutes) for 30 days, after which her symptoms subsided and haematuria disappeared.

Cystoscopic findings demonstrated marked improvement, and no side effects were noted during the course of therapy.

What This Means for Canadian Patients

For Canadian patients experiencing cyclophosphamide-induced haemorrhagic cystitis, hyperbaric oxygenation therapy could be a potential treatment option to alleviate symptoms and improve bladder health.

This therapy might offer relief from severe bleeding and discomfort associated with this chemotherapy side effect.

Canadian Relevance

This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.

Study Limitations

A major limitation of this study is that it is a single case report, preventing generalization of the findings to a broader patient population.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Uncategorised
Source Pubmed
PubMed ID 8586509
Year Published 1995
Journal International urology and nephrology
MeSH Terms Adult; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cystitis; Female; Hemorrhage; Humans; Hyperbaric Oxygenation; Ovarian Neoplasms

Cite This Study

Share

Find a Canadian Clinic Treating Uncategorised

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.